Instead, it was Slaoui, the former GlaxoSmithKline executive who Trump has appointed to lead the vaccine initiative, who delivered yet another strikingly confident prediction.“Mr. President, I have very recently seen early data from a clinical trial with a coronavirus vaccine,” he said to applause. “These data make me feel even more confident that we will be able to deliver a few hundred million doses of vaccine by the end of 2020.”